CBLL on Nasdaq

Ceribell, Inc.

A seizure is an abnormal burst of uncontrolled electrical activity in the brain which, if left untreated, can result in permanent disability or death.4 From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with VASO Corp, BIOLIFE SOLUTIONS INC or ViewRay, or pick any stock.

  • TickerCBLL on Nasdaq2
  • IndustryElectromedical & Electrotherapeutic Apparatus2
  • HeadquartersSunnyvale, United States2
  • Incorporated inDE3
  • Business address360 N. Pastoria Avenue, Sunnyvale, Ca 940853
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3
  • Legal formCorporation2
  • LEI254900XFP5492GQXKO052
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 55952442

See how the biggest companies compare on our leaderboards

A seizure is an abnormal burst of uncontrolled electrical activity in the brain which, if left untreated, can result in permanent disability or death. Seizures are often associated with epilepsy, a chronic condition that causes recurring seizures throughout an individual’s life. However, seizures in the acute care setting are also commonly triggered by serious conditions such as brain tumors, traumatic brain injury, stroke, cardiac arrest, and sepsis, among others. In contrast to epileptic seizures which are short in duration and typically involve convulsions, seizures occurring in the acute care setting tend to be longer in duration and are most often non-convulsive, meaning they lack the physical symptoms that are often used to identify seizure activity, which makes empirical diagnosis extremely challenging. This creates a significant unmet need, and it is estimated that up to 92% of a…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

87.9%Gross margin5
-65.6%Operating margin5
-60.0%Net margin5
36.1%Revenue growth, 20255
-34.4%Return on equity5
-$41.6MFree cash flow5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 76% of the revenue Ceribell, Inc. broke down this way in fiscal 2025.

  1. Product$67.3M576%up 34% from 2024
  2. Subscription$21.7M524%up 41% from 2024
Products and services by year
Products and services20242025
Product$50.1M$67.3M
Subscription$15.4M$21.7M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue12¢$10.8M
  • Research and development21¢$19.1M
  • Other costs66¢$59.1M

Out of $89.1M in revenue.5 The company lost money this year.

Financial statements

Revenue65$89.1M in 2025+97% since 2023
0$25.0M$50.0M$75.0M$100.0M2023: $45.2M$45.2M20232024: $65.4M$65.4M2024+45%2025: $89.1M$89.1M2025+36%
Gross profit65$78.3M in 2025+105% since 2023
0$20.0M$40.0M$60.0M$80.0M2023: $38.2M$38.2M20232024: $56.8M$56.8M2024+49%2025: $78.3M$78.3M2025+38%
Operating income65-$58.4M in 2025+94% since 2023
-$60.0M-$40.0M-$20.0M02023: -$30.0M-$30.0M20232024: -$39.7M-$39.7M2024+32%2025: -$58.4M-$58.4M2025+47%
Net income65-$53.4M in 2025+81% since 2023
-$60.0M-$40.0M-$20.0M02023: -$29.5M-$29.5M20232024: -$40.5M-$40.5M2024+37%2025: -$53.4M-$53.4M2025+32%

Every line of the income statement as filed: the last 2 fiscal years, latest first.5

Period ending2025-12-312024-12-31
Total Revenue$89.1M$65.4M
Total cost of revenue$10.8M$8.7M
Gross profit$78.3M$56.8M
Research and development$19.1M$13.6M
Sales and marketing$73.1M$49.1M
General and administrative$44.5M$33.8M
Total operating expenses$136.7M$96.5M
Loss from operations-$58.4M-$39.7M
Interest expense-$1.9M-$2.0M
Change in fair value of warrant liability$0-$1.5M
Other income, net$6.9M$2.7M
Loss, before provision for income taxes-$53.4M-$40.5M
Provision for income tax expense$0$0
Net loss-$53.4M-$40.5M
Basic-$1.46-$3.39
Diluted-$1.46-$3.39
Basic36.5M shares11.9M shares
Diluted36.5M shares11.9M shares
Unrealized gain on marketable securities$159.0K$0
Comprehensive loss-$53.3M-$40.5M

Compare Ceribell, Inc. with another company

Leadership

Who has led Ceribell, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Xingjuan Chao2024–now

President

  1. Xingjuan Chao2024–now

Chief financial officer

  1. Scott Blumberg2024–now
2025
Board members and other officers (13)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerDan Rogy named Sep 29, 202223
  • Executive OfficerDavid Stoffel named Sep 29, 202223
  • DirectorJoseph Taylor named Sep 29, 202223
  • DirectorJulie Tammenoms Bakker named Sep 29, 202223

Timeline

  1. Oct 10, 2024New chief executive Xingjuan Chao becomes CEO9
  2. Aug 29, 2014Founded Ceribell, Inc. is founded2

Filings

301 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 24 major events, 132 insider forms, 17 large holders, 1 private raises, 119 other. The latest 20:

  1. Oct 2, 20264 EDGAR
  2. Oct 1, 2026144 EDGAR
  3. Sep 17, 20264 EDGAR
  4. Sep 17, 20264 EDGAR
  5. Sep 15, 2026144 EDGAR
  6. Sep 15, 2026144 EDGAR
  7. Sep 10, 20264 EDGAR
  8. Sep 10, 20264 EDGAR
  9. Sep 8, 2026144 EDGAR
  10. Sep 8, 2026144 EDGAR
  11. Sep 4, 20264 EDGAR
  12. Sep 4, 20264 EDGAR
  13. Sep 2, 2026144 EDGAR
  14. Sep 2, 2026144 EDGAR
  15. Aug 25, 20264 EDGAR
  16. Aug 25, 20264 EDGAR
  17. Aug 25, 20264 EDGAR
  18. Aug 25, 20264 EDGAR
  19. Aug 25, 20264 EDGAR
  20. Aug 24, 2026144 EDGAR

The 301 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

84 open-market trades by officers, directors and large owners since October 2021: 2 buys and 82 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 15, 2026Chao XingjuanPresident and CEOSale20,846$25.03$521.8KForm 4
Sep 15, 2026Blumberg ScottChief Financial OfficerSale846$25.00$21.1KForm 4
Sep 8, 2026Foehr DavidSenior VP, Finance and PAOSale9,255$24.25$224.5KForm 4
Sep 8, 2026Woo RaymondChief Technology OfficerSale4,887$24.33$118.9KForm 4
Sep 2, 2026Chao XingjuanPresident and CEOSale39,540$24.61$973.1KForm 4
Sep 2, 2026Blumberg ScottChief Financial OfficerSale652$25.00$16.3KForm 4
Aug 24, 2026Foehr DavidSenior VP, Finance and PAOSale859$23.95$20.6KForm 4
Aug 21, 2026Manni Joseph S.Chief Revenue OfficerSale1,361$24.02$32.7KForm 4
Aug 21, 2026Foehr DavidSenior VP, Finance and PAOSale993$24.02$23.9KForm 4
Aug 21, 2026Woo RaymondChief Technology OfficerSale1,979$24.02$47.5KForm 4
Aug 21, 2026Blumberg ScottChief Financial OfficerSale1,521$24.02$36.5KForm 4
Aug 21, 2026Chao XingjuanPresident and CEOSale6,068$24.02$145.8KForm 4
Aug 19, 2026Blumberg ScottChief Financial OfficerSale33,512$25.03$838.8KForm 4
Aug 19, 2026Chao XingjuanPresident and CEOSale31,415$25.03$786.3KForm 4
Aug 18, 2026Blumberg ScottChief Financial OfficerSale990$25.00$24.8KForm 4
Aug 18, 2026Chao XingjuanPresident and CEOSale2,199$25.00$55.0KForm 4
Aug 13, 2026Taylor Joseph MichaelDirectorSale13,095$23.40$306.4KForm 4
Aug 3, 2026Chao XingjuanPresident and CEOSale39,000$18.32$714.5KForm 4
Jul 7, 2026Chao XingjuanPresident and CEOSale39,000$19.90$776.1KForm 4
Jun 30, 2026BURKE WILLIAM WDirectorSale2,207$19.84$43.8KForm 4

All 84 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Apr 22, 2021Raised $102.5 million in a private offering of equity Form D: 17 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Fmr LLC5,691,393$110.7M0.0%+840,962
Tpg Gp A, LLC3,761,154$73.2M1.5%−206,268
Red Tree Management, LLC2,205,661$42.9M29.1%No change
BlackRock, Inc.1,936,093$37.7M0.0%+122,938
Vanguard Capital Management LLC1,130,346$22.0M0.0%−6,786
KCM Capital Inc1,125,000$21.9M3.6%−275,000
Federated Hermes, Inc.939,600$18.3M0.0%+136
Franklin Resources Inc918,349$17.9M0.0%+108,835
Adage Capital Partners Gp, L.l.c.900,000$17.5M0.0%+143,249
Bank of New York Mellon Corp896,488$17.4M0.0%−264,279
TimesSquare Capital Management, LLC780,552$15.2M0.2%+64,084
Millennium Management LLC727,225$14.1M0.0%+175,204
Geode Capital Management, LLC668,134$13.0M0.0%+56,157
Royce & Associates LP605,010$11.8M0.1%+89,290
State Street Corp547,035$10.6M0.0%+21,603
Silvercrest Asset Management Group LLC468,806$9.1M0.1%−20,936
Massachusetts Financial Services Co /ma/389,675$7.6M0.0%−118,815
Redmile Group, LLC386,786$7.5M0.5%No change
Jpmorgan Chase & Co345,152$6.9M0.0%+57,946
Yu Fan342,398$6.7M6.2%−207,050
Peregrine Capital Management LLC331,413$6.4M0.2%−16,806
Creek Drive Management Group LLC300,881$5.9M3.6%−22,119
Morgan Stanley285,661$5.6M0.0%+54,743
Goldman Sachs Group Inc280,309$5.5M0.0%−130,722
ABG-WTT Global Life Science Capital Partners GP Ltd275,328$5.4M62.6%−166,492

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32